148 related articles for article (PubMed ID: 17907131)
21. 4-Substituted anilides as selective melatonin MT2 receptor agonists.
Epperson JR; Deskus JA; Gentile AJ; Iben LG; Ryan E; Sarbin NS
Bioorg Med Chem Lett; 2004 Feb; 14(4):1023-6. PubMed ID: 15013015
[TBL] [Abstract][Full Text] [Related]
22. Tetrahydroisoquinoline derivatives as melatonin MT2 receptor antagonists.
Karageorge GN; Bertenshaw S; Iben L; Xu C; Sarbin N; Gentile A; Dubowchik GM
Bioorg Med Chem Lett; 2004 Dec; 14(23):5881-4. PubMed ID: 15501061
[TBL] [Abstract][Full Text] [Related]
23. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological activity of new melatonin dimeric derivatives.
Di Giacomo B; Bedini A; Spadoni G; Tarzia G; Fraschini F; Pannacci M; Lucini V
Bioorg Med Chem; 2007 Jul; 15(13):4643-50. PubMed ID: 17481904
[TBL] [Abstract][Full Text] [Related]
25. Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors.
Phillips ST; de Paulis T; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
J Med Chem; 1994 Aug; 37(17):2686-96. PubMed ID: 8064797
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the involvement of the monoaminergic system in the antidepressant-like action of two 4-amine derivatives of 10,11-dihydro-5H-dibenzo [a,d] cycloheptane in mice evaluated in the tail suspension test.
Duarte FS; Lach G; Martins PR; Romeiro GA; de Lima TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):368-74. PubMed ID: 17920179
[TBL] [Abstract][Full Text] [Related]
27. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation.
Elsner J; Boeckler F; Davidson K; Sugden D; Gmeiner P
Bioorg Med Chem; 2006 Mar; 14(6):1949-58. PubMed ID: 16290939
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
30. 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
Faust R; Garratt PJ; Trujillo Pérez MA; Piccio VJ; Madsen C; Stenstrøm A; Frølund B; Davidson K; Teh MT; Sugden D
Bioorg Med Chem; 2007 Jul; 15(13):4543-51. PubMed ID: 17459711
[TBL] [Abstract][Full Text] [Related]
31. Experiments in the 5H-dibenzo(a,d)cycloheptene series. IV. Synthesis and pharmacology of some 10-mono and 5,10-disubstituted 5H-dibenzo(a,d)cycloheptenes.
Gootjes J; Funcke AB; Nauta WT
Arzneimittelforschung; 1969 Dec; 19(12):1936-8. PubMed ID: 4392321
[No Abstract] [Full Text] [Related]
32. The anticonvulsive activity in mice of a number of derivatives of 5H-dibenzo(a,d)cycloheptene and its 1- and 3-aza analogues, in comparison with some therapeutically used anticonvulsants.
Funcke AB; Zandberg P
Arzneimittelforschung; 1970 Dec; 20(12):1896-900. PubMed ID: 5537092
[No Abstract] [Full Text] [Related]
33. An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT(2) melatonin receptor antagonist.
Lucarini S; Bedini A; Spadoni G; Piersanti G
Org Biomol Chem; 2008 Jan; 6(1):147-50. PubMed ID: 18075659
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
36. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
[TBL] [Abstract][Full Text] [Related]
37. New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists.
Borza I; Greiner I; Kolok S; Galgóczy K; Ignácz-Szendrei G; Horváth C; Farkas S; Gáti T; Háda V; Domány G
Pharmazie; 2006 Sep; 61(9):799-800. PubMed ID: 17020160
[TBL] [Abstract][Full Text] [Related]
38. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and SAR studies of a novel class of S1P1 receptor antagonists.
Nakamura T; Yonesu K; Mizuno Y; Suzuki C; Sakata Y; Takuwa Y; Nara F; Satoh S
Bioorg Med Chem; 2007 May; 15(10):3548-64. PubMed ID: 17379528
[TBL] [Abstract][Full Text] [Related]
40. 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.
Ulven T; Frimurer TM; Receveur JM; Little PB; Rist O; Nørregaard PK; Högberg T
J Med Chem; 2005 Sep; 48(18):5684-97. PubMed ID: 16134937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
